Evidence map›Paper›PMID 12759718›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2003

Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain.

Catherine Videau, Ute Hochgeschwender, Hans Jürgen Kreienkamp, Miles B Brennan, Cécile Viollet, Dietmar Richter, Jacques Epelbaum

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

  1. The Primary Cilia are Associated with the Axon Initial Segment in Neurons.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Cell-Type-Specific Effects of Somatostatin on Synaptic Transmission in the Anterior Cingulate Cortex.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Somatostatin contributes to in vivo gamma oscillation modulation and odor discrimination in the olfactory bulb.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  15. Article
  16. Article
  17. Somatostatin receptor subtype 4 couples to the M-current to regulate seizures.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008
    Article
  18. Somatostatin receptor 2 is activated in cortical neurons and contributes to neurodegeneration after focal ischemia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Catherine VideauU.549 INSERM IFR Broca-Sainte Anne, 2 ter rue d'Alésia, 75014 Paris, France.
Ute Hochgeschwender
Hans Jürgen Kreienkamp
Miles B Brennan
Cécile Viollet
Dietmar Richter
Jacques Epelbaum
Centre Paul Broca · FREppendorf (Germany) · DEInserm · FROklahoma Medical Research Foundation · USRoosevelt Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five somatostatin receptors (sst) have been cloned and mRNAs for the first four (sst1-4) are expressed in many brain regions. In the present work, we compared the distribution of the non-selective ligand [125I]-Tyr0-DTrp8-SRIF14 by autoradiography in 24 brain regions and pituitary in wild type, sst1- to sst4- or SRIF-gene invalidated (KO) mice. [125I]-Tyr0-DTrp8-SRIF14 binding was not significantly modified in sst1 KO mouse brain with the noticeable exception of the substantia nigra and only moderately decreased in pituitary. For sst2 KO mice, a general decrease (>75%) was observed in most regions, with the noticeable exception of the olfactory bulb and CA1 field of the hippocampus. SST3 KO brain displayed a decrease in binding in the external plexiform layer of the olfactory bulb only (-54%). For sst4 KO mice, [125I]-Tyr0-DTrp8-SRIF14 binding levels in the external plexiform (-35%) and glomerular (-39%) layers of the olfactory bulb as well as the hippocampus CA1 field (-68%) were significantly decreased. In SRIF KO mice, a significant increase in binding levels was observed in olfactory bulb, anterior olfactory nucleus, frontal cortex upper layers, lateral septum, CA1 field, zona incerta and lateral hypothalamus, substantia nigra, periaqueductal grey and parabrachial nucleus. Competition with selective ligands (CH275, octreotide or L-779,976, L-796,778, L-803,087, and octreotide or L-817,778, for sst1-5 receptors, respectively) was in accordance with these findings. Moreover, octreotide was still able to compete on residual [125I]-Tyr0-DTrp8-SRIF14 binding sites in sst2 KO pituitary. It is concluded that most [125I]-Tyr0-DTrp8-SRIF14 binding sites in mouse brain and pituitary belong to the sst2 subtype but for the olfactory bulb (sst3 and sst4 receptors), the CA1 of the hippocampus (sst4 receptors) and the pituitary (sst5 and sst1 receptors) in which other subtypes are also expressed. The overall increase in [125I]-Tyr0-DTrp8-SRIF14 binding in SRIF KO mice indicates that SRIF receptors, mostly from the sst2 subtype, are regulated by the endogenous ligand(s).

Indexed as

Gene DeletionAnimalsBrainFemaleIodine RadioisotopesMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutOctreotideProtein BindingReceptors, SomatostatinSomatostatinIodine RadioisotopesMembrane ProteinsOctreotideReceptors, SomatostatinSomatostatinsomatostatin, N-Tyr(1)-somatostatin receptor 3somatostatin receptor sst2Asomatostatin receptor subtype-4Sstr2 protein, mouse

Identifiers

PMID12759718
OpenAlexW2020130383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.